Medifocus Inc. | Cash Flow

Fiscal year is April-March. All values CAD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
6,134.30
6,796.20
6,509.20
2,060.50
1,978.20
Depreciation, Depletion & Amortization
383.30
410.70
472.80
476.10
478.60
Other Funds
-
1,776.60
-
-
-
Funds from Operations
4,832.10
4,873.90
4,255.60
1,222.50
1,488.60
Changes in Working Capital
456.80
1,663.00
1,713.90
274.20
1,516.30
Net Operating Cash Flow
5,288.80
3,210.90
2,541.60
948.30
27.70
Capital Expenditures
16.10
50.80
84.00
4.70
23.60
Sale of Fixed Assets & Businesses
-
-
-
274.30
-
Purchase/Sale of Investments
-
-
131.20
-
-
Net Investing Cash Flow
16.10
50.80
47.20
269.60
23.60
Issuance/Reduction of Debt, Net
4,870.70
203.10
-
656.30
-
Net Financing Cash Flow
4,870.70
3,217.20
935.40
656.30
-
Net Change in Cash
434.20
22.70
1,572.40
57.30
58.00
Free Cash Flow
5,304.90
3,261.70
2,625.60
953.00
4.10
Change in Capital Stock
-
1,643.70
935.40
-
-
Exchange Rate Effect
-
67.20
13.40
34.90
54.00

About Medifocus

View Profile
Address
10240 Old Columbia Road
Columbia Maryland 21046
United States
Employees -
Website http://www.medifocusinc.com
Updated 07/08/2019
Medifocus, Inc. is engaged in the business of development and commercialization of minimally invasive, unique focused heat treatment systems used in treatment of cancerous and benign tumors, and enlarged prostate. It owns two technology platforms: Endo-thermotherapy and Adaptive Phased Array Microwave Focusing. The company was founded on April 25, 2005 and is headquartered in Toronto, Canada.